Biểu đồ giá cổ phiếu OTLC
OTLC Dự đoán giá cổ phiếu
Oncotelic Therapeutics Inc
$0.03
5.56%
$0
Khi đóng cửa: May 07, 16:00:00 GMT-4
$0.03
1.28%
$0
Phiên sau giờ: May 07, 20:00:00 GMT-4
Quay lại
Oncotelic Therapeutics Inc (OTLC) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$0.0367
Giá mở cửa
$0.038
Phạm vi ngày
$0.0376 - $0.0393
Phạm vi 52 tuần
$0.02 - $0.11
Khối lượng
--
Khối lượng trung bình
274.9K
Tỷ suất cổ tức
--
EPS (TTM)
-0.00
Vốn hóa thị trường
$17.3M
OTLC là gì?
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. The company is headquartered in Agoura Hills, California and currently employs 26 full-time employees. The firm has three primary drugs and AI technology programs: AL-101 - Intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of Parkinson’s Disease (PD), erectile dysfunction (ED) and female sexual dysfunction (FSD); CA4P- a vascular disrupting agent (VDA) - in combination with Ipilimumab for the treatment of solid tumors with focus on melanoma in adult and pediatric melanoma; Oxi4503- a second generation VDA - for the treatment of liquid tumors with focus on childhood leukemia; OT-101 - an antisense against TGF-b2-for the treatment of various cancers and for the treatment of various viruses, and Artemisinin-a natural derivative from an Asian herb Artemisia Annua.
